Related Experiment Videos
Rat liver pathomorphology during prolonged sodium valproate administration
M Sobaniec-Lotowska1, W Sobaniec, W Kułak
1Department of Pathological Anatomy, Medical Academy, Białystok, Poland.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy
|January 1, 1993
Summary
Long-term use of sodium valproate in rats caused progressive liver damage, including fatty changes and cell degeneration. These hepatic lesions appeared reversible after 12 months of antiepileptic drug administration.
Area of Science:
- Hepatology
- Pharmacology
- Toxicology
Background:
- Sodium valproate is a widely prescribed antiepileptic drug.
- Understanding its long-term hepatic effects is crucial for patient safety.
Purpose of the Study:
- To investigate the chronic effects of sodium valproate on rat liver morphology.
- To determine the progression and nature of hepatic lesions induced by prolonged drug administration.
Main Methods:
- Rats were administered sodium valproate (200 mg/kg/day) for 1, 3, 6, 9, and 12 months.
- Hepatic tissues were analyzed for morphological changes using microscopy.
Main Results:
- Hepatic lesions were first observed at 3 months and progressively worsened over 12 months.
- Key changes included microvesicular fatty change, vacuolar degeneration of periportal hepatocytes, focal necrosis, inflammation, and congestion.
- No significant proliferation of connective tissue was noted.
Conclusions:
- Prolonged sodium valproate administration induces dose-dependent hepatic morphological lesions in rats.
- The observed liver abnormalities, characterized by cellular damage and inflammation, appear to be reversible.